|
|
Article: Commonwealth Biotechnologies, Inc. Announces Definitive Share Purchase Agreement to Acquire GL Biochem (Shanghai) and Associated Businesses.
- Article from:
- Business Wire
- Article date:
- September 3, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
RICHMOND, Va. -- Commonwealth Biotechnologies, Inc. ("CBI") (NASDAQ Capital Market: CBTE) is pleased to announce that it has executed a definitive agreement to acquire all of the outstanding shares of GL Biochem (Shanghai) Ltd, ("GL") as well as all of the outstanding shares of GL Biochem (Danyang) Ltd, GL Peptide (Binhai) Ltd, and 86% of the shares of GL Peptide (Shanghai) Ltd, three businesses affiliated with GL (collectively, the "GL Group"). The GL Group is the largest global supplier of research-grade peptide products and peptide reagents. CBI management anticipates that the acquisition of the GL Group, in combination with revenues from CBI's existing peptide ...